Table 2. Prevalence of metabolic syndrome, its components, and atherogenic dyslipidemia by servings/week of nuts.
| Nut consumption | ||||
| <1 serving/week(n = 2796) | 1–3 servings/week(n = 2125) | >3 servings/week(n = 2289) | P value1 | |
| Metabolic syndrome, % (n) | 69.7 (1770) | 64.3 (1266) | 59.9 (1251) | <0.001 |
| Abdominal obesity, % (n) | 77.6 (2089) | 74.4 (1546) | 66.7 (1487) | <0.001 |
| Hypertriglyceridemia, % (n) | 33.1 (842) | 29.5 (578) | 30.0 (635) | 0.014 |
| Low HDL-cholesterol, % (n) | 33.2 (841) | 31.2 (613) | 28.3 (602) | 0.001 |
| High blood pressure, % (n) 2 | 94.3 (2625) | 93.7 (1984) | 94.7 (2155) | 0.356 |
| Fasting plasma glucose ≥100 mg/dL, % (n) | 69.7 (1784) | 64.1 (1267) | 65.8 (1365) | <0.001 |
| Atherogenic dyslipidemia, % (n) 3 | 14.9 (378) | 12.5 (244) | 11.5 (245) | 0.002 |
1
Chi-square test.
2
Defined as blood pressure ≥130/85 mmHg or antihypertensive drug treatment.
3
Defined as serum triglycerides ≥150 mg/dL associated with HDL-cholesterol <40 mg/dL in men or <50 mg/dL in women.